As of 2024-12-11, the Relative Valuation of Sutro Biopharma Inc (STRO) is (47.69) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.81 USD, the upside of Sutro Biopharma Inc based on Relative Valuation is -1797.1%.
The range of the Relative Valuation is (53.06) - (49.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 35.3x - 38.1x | 36.7x |
| Forward P/E multiples | 20.9x - 32.6x | 26.8x |
| Fair Price | (53.06) - (49.00) | (47.69) |
| Upside | -1988.3% - -1843.9% | -1797.1% |
| Date | P/E |
| 2024-12-02 | -1.83 |
| 2024-11-29 | -1.76 |
| 2024-11-27 | -1.79 |
| 2024-11-26 | -1.73 |
| 2024-11-25 | -1.74 |
| 2024-11-22 | -1.67 |
| 2024-11-21 | -1.68 |
| 2024-11-20 | -1.78 |
| 2024-11-19 | -1.80 |
| 2024-11-18 | -1.83 |
| 2024-11-15 | -1.92 |
| 2024-11-14 | -2.30 |
| 2024-11-13 | -2.63 |
| 2024-11-12 | -2.71 |
| 2024-11-11 | -2.93 |
| 2024-11-08 | -2.91 |
| 2024-11-07 | -2.77 |
| 2024-11-06 | -2.75 |
| 2024-11-05 | -2.55 |
| 2024-11-04 | -2.45 |
| 2024-11-01 | -2.36 |
| 2024-10-31 | -2.16 |
| 2024-10-30 | -2.37 |
| 2024-10-29 | -2.36 |
| 2024-10-28 | -2.38 |
| 2024-10-25 | -2.30 |
| 2024-10-24 | -2.30 |
| 2024-10-23 | -2.33 |
| 2024-10-22 | -2.35 |
| 2024-10-21 | -2.42 |
| 2024-10-18 | -2.48 |
| 2024-10-17 | -2.47 |
| 2024-10-16 | -2.51 |
| 2024-10-15 | -2.55 |
| 2024-10-14 | -2.55 |
| 2024-10-11 | -2.52 |
| 2024-10-10 | -2.20 |
| 2024-10-09 | -2.30 |
| 2024-10-08 | -2.34 |
| 2024-10-07 | -2.36 |
| 2024-10-04 | -2.40 |
| 2024-10-03 | -2.35 |
| 2024-10-02 | -2.34 |
| 2024-10-01 | -2.33 |
| 2024-09-30 | -2.30 |
| 2024-09-27 | -2.33 |
| 2024-09-26 | -2.32 |
| 2024-09-25 | -2.21 |
| 2024-09-24 | -2.26 |
| 2024-09-23 | -2.39 |